Eva Lee
8Patents
3h-index
11Co-inventors
50Inventor score
Filing activity: Sep 17, 1987 → Dec 21, 2001
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5851991A | Therapeutic use of the retinoblastoma susceptibility gene product | Chemistry; Metallurgy | 13 | Expired |
| US4942123A | ppRB.sup.110 -phosphoprotein the retinoblastoma susceptibility gene product | Emerging Cross-Sectional Technologies | 13 | Expired |
| US5858771A | Products and methods for controlling the suppression of the neoplastic phenotype | Chemistry; Metallurgy | 5 | Expired |
| US5998134A | Retinoblastoma gene-cancer suppressor and regulator | Chemistry; Metallurgy | 2 | Expired |
| US6051396A | Method for producing retinoblastoma gene protein products | Chemistry; Metallurgy | 1 | Expired |
| US5578701A | ppRB.sup.110 - nuclear phosphoprotein - the retinoblastoma susceptibility gene product | Emerging Cross-Sectional Technologies | 1 | Expired |
| US7105156B1 | Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproliferating cells | Chemistry; Metallurgy | 1 | Expired |
| US7060688B2 | Products and methods for controlling the suppression of the neoplastic phenotype | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.